Adial Pharmaceuticals, Inc.
ADILNasdaqCIK 1513525HealthcareFiscal year ends Dec 31
Reports and events: 234 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2120:25 ET | 10-Q/A | Quarterly report, amendedPeriod 2026-06-30 | 0001213900-26-111121 |
| 2026-10-1617:15 ET | 8-K | 8.01 Other events | 0001213900-26-110349 |
| 2026-10-0216:16 ET | 8-K | 8.01 Other events | 0001213900-26-106395 |
| 2026-09-1816:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-101434 |
| 2026-09-1617:08 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100574 |
| 2026-08-2516:33 ET | 8-K | 3.02 Unregistered sale of equity | 0001213900-26-093544 |
| 2026-08-2416:05 ET | DEF 14A | Proxy statementPeriod 2026-09-17 | 0001213900-26-093019 |
| 2026-08-2117:17 ET | 8-K | 3.01 Delisting notice | 0001213900-26-092690 |
| 2026-08-1707:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-090482 |
| 2026-08-1416:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090051 |
| 2026-08-1317:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001213900-26-089270 |
| 2026-08-1121:13 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-26-087439 |
| 2026-06-1112:43 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-067711 |
| 2026-05-1108:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054219 |
| 2026-05-0816:21 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-053907 |
| 2026-04-0917:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-042057 |
| 2026-03-0608:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-024336 |
| 2026-03-0517:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-024175 |
| 2026-03-0308:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-022718 |
| 2026-02-2409:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019639 |
| 2026-02-0416:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-012274 |
| 2026-01-0616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-001790 |
| 2026-01-0616:15 ET | DEF 14A | Proxy statementPeriod 2026-02-26 | 0001213900-26-001792 |
| 2025-12-0116:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-116666 |
| 2025-11-1408:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-110385 |
| 2025-11-1316:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-109979 |
| 2025-09-1608:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-087925 |
| 2025-09-0308:48 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-083719 |
| 2025-08-1408:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076085 |
| 2025-08-1316:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075695 |
| 2025-08-0116:51 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-070671 |
| 2025-08-0116:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-070642 |
| 2025-07-1608:30 ET | 8-K | 8.01 Other events | 0001213900-25-064467 |
| 2025-07-1016:30 ET | 8-K | 8.01 Other events | 0001213900-25-062800 |
| 2025-06-1817:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-055700 |
| 2025-06-1617:20 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001213900-25-054839 |
| 2025-06-1317:26 ET | S-1/A | Registration statement, amended | 0001213900-25-054387 |
| 2025-06-1017:28 ET | DEF 14A | Proxy statementPeriod 2025-07-24 | 0001213900-25-053170 |
| 2025-06-0608:34 ET | S-1 | Registration statement | 0001213900-25-051752 |
| 2025-05-3016:01 ET | 8-K | 3.01 Delisting notice | 0001213900-25-049451 |
| 2025-05-1508:40 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-043733 |
| 2025-05-1508:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-043730 |
| 2025-05-1416:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-043281 |
| 2025-05-0717:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-040724 |
| 2025-05-0116:09 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-038442 |
| 2025-03-2116:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-25-000999 |
| 2025-03-0716:15 ET | 8-K | 3.01 Delisting notice | 0001213900-25-021738 |
| 2025-03-0408:57 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-019779 |
| 2025-03-0408:49 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-019771 |
| 2025-02-2509:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-016826 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 06:04 ET. Listed shows no prices and gives no investment advice.